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Montana State University, Department of Chemistry and Biochemistry, 2College of Saint Benedict, Department of Chemistry

Dendrimers—highly branched macromolecules—present an attractive option for use as a catalytic framework because
of their large size and their availability for functionalization. In addition, the use of organocatalysts to form
asymmetric products has become an increasingly studied field in the pharmaceutical industry and cancer research.
Organocatalyst terminally functionalized dendrimers present the possibility of both catalytic utility and increased
recovery in MacMillan-type asymmetric reactions. Terminal sites of generations 2.0, 3.0, and 4.0 PAMAM
dendrimers have been functionalized with the MacMillan group's (2S, 5S)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one catalyst. These functionalized PAMAM dendrimers were characterized by NMR and MALDITOF MS analysis. The organocatalyst functionalized dendrimers show promising yield, enantioselectivity, and
recoverability in MacMillan-type organocatalytic reactions.

INTRODUCTION
of organo-catalysis had a huge increase in the
Organo-catalysts are a classification of catalyst

amount of attention it drew.

that are comprised of mostly carbon, hydrogen,

asymmetric catalysis sparked more research into

oxygen, and nitrogen atoms. Organic molecules

different classes of organocatalyst. During this

used for catalysis have a long history, but recent

gain in attention, another influential class of

interest in organo-catalysis has been turned to

catalysts,

imidazolidinone

This gain in

catalysts,

were

2

catalysts that can produce enantioselective and

developed by David MacMillan by modifying

diasteroselective

the naturally occurring chiral phenylalanine. The

(optically

active)

products.

Relatively recently, in the 1970s, a revolutionary

MacMillan

research

group

at

Princeton

reaction called the Hajos-Parrish-Eder-Sauer-

University in New Jersey currently works to

Wiechert reaction was carried out by using a

develop different organo-catalysts to aid in a wide

naturally occurring chiral reagent, proline, as a

range of reactions, some of which are prevalent in

catalyst to promote the synthesis of a chiral aldol

the pharmaceutical industry and also utilized in

reaction product.1 After this asymmetric reaction

the total synthesis of natural products.3

catalyzed by an organo-catalyst was reported and
shown to be extremely enantioselective, the field
1

The

organo-catalysts

developed

by

the

MacMillan group are important for a variety of

using dendrimers as an organic scaffold onto
which the catalyst can be synthesized.

organic syntheses. These syntheses include high
enantioselectivity for various commonly observed

Dendrimers are synthetic polymers that have a

asymmetric organocatalytic reactions (diels-alder,

treelike structure—whose “branches” emanate

aldol addition, and nucleophilic addition) as well

from a single point called a core. PAMAM

4

as cascade catalysis. The catalysts developed for

(poly(amido amine)) dendrimers are a common

these reactions produce enantioselective and

class of dendrimer used in many different

diastereoselective products, which are of interest

materials science and biotechnology applications

to many organizations and research efforts. Most

due to their physical properties. Dendrimers can

commonly,

optically

are

be synthesized with different cores and terminal

extremely

important

pharmaceutical

end groups. The synthetic route being taken in

applications where different stereoisomers can

this project utilizes specific generations of

play very different roles in the body.5 Because of

PAMAM dendrimers, which have an ethylene

their wide variety of uses and the procedure used

diamine core, branches that contain amide

in synthesizing the organo-catalysts, the organo-

groups, and terminate in amine groups (Figure 1).

catalysts developed by MacMillan are relatively

PAMAM dendrimers are symmetrical and adopt

expensive to purchase.6 As of now, the catalysts

a relatively spherical shape. The terminal amine

are difficult to recover and purify for reuse,

ends of the “branches,” or end groups, are

leading to disposal and therefore making any

relatively monodisperse over the molecule’s

synthesis involving the catalyst expensive and

spherical surface.

inefficient.

reactive as nucleophiles and therefore present a

active
in

molecules

These amine groups are

unique opportunity as a site for functionalization
By modifying how MacMillan’s catalysts are

(addition of molecules to the amine end groups)

introduced into a reaction and building multiple

of the PAMAM end groups. PAMAM

catalytic units onto a large organic framework

dendrimer solubility also typically mimics the

instead of introducing them into a reaction as

solubility of their terminal groups, which is

discrete molecules, the effective size of the

important for keeping reaction conditions

catalytic unit increases. This increase in size leads

relatively consistent when investigating the use of

to more recoverability options for the catalysts,

dendrimers in catalysis. PAMAM dendrimers

and can make syntheses involving MacMillan’s

can be purchased or synthesized in multiple

catalysts more efficient since the catalysts can be

generations as well—Generations 2.0, 3.0, and

recovered and reused. This project focuses on

4.0 PAMAM dendrimers will be used for this
project, which have 16, 32, and 64 amine-

2

terminated

end

groups

available

for

functionalization with the desired organo-

be utilized with dendrimers or other similar
macromolecules.

catalyst, respectively.7
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Figure 2: Varying Dendrimer Catalyst Delivery Motifs
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Figure 1: A Generation 2.0 PAMAM Dendrimer

PAMAM dendrimers were chosen in particular
for this work due to their properties for an ideal
platform for catalysis. Their spherical shape,

Dendritic catalysis has become an increasingly

solubility properties, organic structure, and

important and studied field. Three structural

monodisperse end groups make them attractive as

motifs that utilize the dendritic macromolecule as

a framework for organocatalysis. The spherical

a catalyst delivery system have been investigated

shape and monodisperse end groups of a

(Figure 2). In the first motif, the core of the

PAMAM dendrimer are an optimal way to

dendrimer is the single catalytic unit in dendrimer

deliver a catalyst to a system because the catalytic

1.8 The second, the “dendritic box” motif 2,

site is on the surface of the molecule, leading to

utilizes pockets inside the dendrimer formed by

ready accessibility to reagents for catalysis.

the placement of its branches to capture and

Solubility properties of PAMAM dendrimers

deliver the catalytic unit.9 The third motif 3,

typically mimic those of the end groups,

incorporating the largest number of catalytic

especially in higher generations. This provides

units, covalently binds catalytic units to the

the opportunity to keep solvent reaction

terminal ends of the dendrimer.10-14 Using the

conditions consistent between dendrimer-bound

motif in 3 and covalently binding the catalyst to

catalysis and catalysis using free, unbound

the amine end groups of the PAMAM dendrimer

catalysts. The organic structure of the PAMAM

framework is ideal for our method of dendritic

catalysts provides the option of covalently binding

catalysis because it allows separation of the

molecules to the terminal end-groups.

catalyst with any method of separation that could

3

By exploiting the reactive amino end groups,
functionalizing the PAMAM dendrimers with
MacMillan's (2S, 5S)-5-(1-benzyl-1H-indol-3yl)-2-tert-butyl-3-methyl-imidazolidin-4-one
catalyst (therefore increasing the effective size of
the catalytic delivery framework) provides a route
for catalyst purification. The size of the organo-

4

6

5

catalyst functionalized dendrimers theoretically

Figure 3: Dendrimer generations 2.0-4.0 Functionalized with

introduce the opportunity for recovery and reuse

MacMillan’s (2S, 5S)-5-(1-benzyl-1H-indol-3-yl)—tert-butyl-

by

filtration,

dialysis,

or

size

exclusion

3-methyl-imidazolidin-4-one catalyst.

chromatography, which makes the MacMillan
group’s procedures more economically feasible

Dendrimers 4-6 were functionalized using an

and environmentally friendly. Recovery and reuse

approach

of this catalyst could impact the fields of green

functionalization by Koskinen and coworkers15 in

chemistry as well as the pharmaceutical industry.

order to develop the synthetic scheme to produce

adapted

from

a

related

the desired imidazolidinone catalyst (Scheme 1).
DISCUSSION

Coupling of N- fluorenylmethyloxycarbonyl
(fmoc) protected L-phenylalanine with the free

Catalyst Functionalization of Dendrimers

amine surface of each generation of PAMAM

A set of three PAMAM dendrimers 4-6 were

dendrimer

functionalized

hydroxybenzotriazole

with

a

MacMillan-type

was

completed
and

under

diisopropyl-

imidazolidinone catalyst known to perform

carbodiimide conditions. Deprotection of the

enantioselective catalysis (Figure 3). Although

resulting material 7 was accomplished with

the dendrimer bound catalysts illustrated only

piperidine

show one catalytic unit per dendrimer, these

functionalized

dendrimer

schematics symbolize fully mono-functionalized

dendrimer

with

dendrimers with the number of end groups

dimethylformamide resulted in the mono-

functionalized respective to their generation.

functionalized dendrimers 4-6.

to

reveal

the

phenylalanine-

8. Treating
pivaldehyde

the
in

4

piperidine in the deprotection step. This one-pot
synthesis streamlined separation of fmoc from the
phenylalanine-functionalized

dendrimer

8.

Completing steps one and two in Scheme 1 as a
one-pot synthesis also maximized recovery of 8
7

8

4, 5, 6

due to no loss of 7 in an unnecessary and time
consuming purification step.

Scheme 1

8,

The method that was adapted for the PAMAM

Functionalized

dendrimer functionalization in Scheme 1 was not

functionalized dendrimers 4,5,6 were purified via

initially intended or optimized for varying

dialysis in DMSO. Since DMSO was found to

generations of PAMAM dendrimer. Work on

be trapped inside of the dendritic material, an

this project also included optimization of

additional step to drive solvent from the material

reagents, reaction conditions, and purification

was needed. When DMSO from dialysis is being

methods for the synthesis in Scheme 1. Reagent

removed via lyophilization, millipore water is

amounts were scaled appropriately for the

added to the mixture to drive DMSO from the

number of amino end groups on the dendrimer,

internal dendritic framework as well as creating

instead of a linear molar ratio. Reaction times

diluted solution of DMSO and water that aides

were increased in order to allow reagents to

in the removal of solvent from the dendrimer

navigate through the dendritic framework and

material, as water has a higher vapor pressure

react with terminal amino end groups. The pH of

(17.54 mmHg)18 than DMSO (0.42 mmHg)19.

reactions were adjusted to be compatible with

This results in the DMSO almost completely

PAMAM dendrimer structure (pH 4-9). The

leaving the internal dendritic framework by

first two steps in Scheme 1 were found to be able

lyophilization to provide more accurate yields by

to be completed in dimethylsulfoxide (DMSO)

weight as well as not interfering with any

instead of dimethylformamide (DMF) in order to

characterization methods. Additionally, in the

minimize hazardous chemical exposure and wear

process of developing the parameters shown in

on lab instruments.16,17

Pi-stacking of excess

Scheme 1, it was found that cyclization of the

fmoc-phenyalanine

with

dendrimer-

catalyst in step 3 of Scheme 1 was sometimes not

functionalized fmoc-phenylalanine inside the

completely successful due to excess solvent, not

dendritic framework required that steps one and

enough reagent, or not long enough of a reaction

two in Scheme 1 were completed as a one-pot

time. In these cases, it was found that if the

synthesis in order to drive all fmoc from the

material was re-submitted to the reaction

dendritic framework at once with an excess of

conditions in step 3 of Scheme 1, additional

dendrimer

as

well

as

5

cyclization would occur, further functionalizing

imidazolidinone catalyst that was built onto the

the dendrimer with the desired catalyst. During

dendritic framework (Schemes 2, 3).20,21

the course of this work the parameters for step 3
of Scheme 1, including amounts of solvent,
reagent, and reaction time, were optimized. The
methods used to cyclize the catalyst are now
efficient enough to produce quantitative yields of

Scheme 2

dendrimer functionalized with cyclized catalyst in
one ring-closing reaction. For the purification of
the resultant fully functionalized dendrimerbound catalyst, DMF must be evaporated via

Scheme 3

lyophilization before submitting the material to
dialysis, since DMF will degrade the dialysis

The reactions in Scheme 2 and 3 were chosen to

tubing (made of regenerated cellulose) that is

demonstrate the catalytic utility of the dendrimer

compatible with DMSO.

because they were within the range of what is
compatible with the framework of a PAMAM
4-6

were

dendrimer. The reactions in Schemes 2 and 3

C NMR

were run at room temperature. This is

spectroscopy techniques as well as matrix assisted

advantageous as low temperatures cannot be

laser

time-of-flight

supported for more than 8 hours in our lab, and

(MALDI-TOF) mass spectrometry. Multiple

temperatures over 30°C can degrade the

matrices used for MALDI-TOF-MS were

framework of the dendrimer. The reactions

investigated in order to optimize dendrimer

chosen were also performed in a pH range that

characterization, including trans-3-indoleacrylic

was adequate for the dendrimer framework, as the

acid (IAA) and 2,5-dihydroxybenzoic acid

framework can also degrade over pH of 9, and at

(DHB). Optimal MALDI-TOF-MS results

pHs lower than 3, the amine groups inside the

were obtained using DHB as a matrix.

dendrimer are ionized and the dendrimer can

The resultant new

dendrimers

characterized using 1H NMR and
desorption

ionization

13

precipitate out of solution as a salt. Since these
Catalytic

Activity

of

Catalyst-Functionalized

are screening reactions, the reactions in Scheme 2

Dendrimers

and 3 were also chosen due to their readily

Functionalized PAMAM dendrimers 4-6 were

available or relatively inexpensive reagents.

evaluated

for

their

ability

to

promote

enantioselective catalysis using selected reactions

In order to gather sufficient evidence to support

catalyzed

our dendrimer-bound catalyst’s utility, reactions

by

the

MacMillan-type

6

shown in Scheme 2 and 3 were run under only

because of the freezing point of DMSO at 19°C.22

acidic conditions (no catalyst), the original

Though the reaction cannot be cooled, it was

conditions published (free catalyst), and with the

found that it had no noticeable effect on the yield

dendrimer-bound catalysts 4, 5, 6. The time until

or enantioselectivity of the reaction. If the solvent

reaction completion, percent yield, optical

used in the nucleophilic addition reaction is

activity, and catalyst recovery were compared to

DCM, parafilm should not be used in order to

values reported by the MacMillan group.

prevent DCM from leeching the hard-to-

Enantiomeric

separate parafilm into the reaction mixture.

excess

was

determined

via

polarimetry in chloroform.
Since the nucleophilic addition reaction in
Solvent Studies and Other Notable Observations

Scheme 3 is run in acidic conditions, there is also

Although dendrimer solubility generally mimics

a reaction acidifying step. The amount of acid in

the solubility of their end groups, lower

the original reaction is the amount needed to

generations of PAMAM dendrimers can exhibit

acidify all of the catalyst material. However, in a

different solubility properties in certain organic

system using the dendrimer-bound catalyst, some

solvents because of their less spherical shape

of the internal framework of the dendrimer is

(compared to higher generations) and exposed

protonated before the catalytic groups on the

internal structure. A series of control reactions for

surface of the dendrimer. It was found that the

the aniline addition reaction in different solvents

amount of acid needed to be increased in a

were used in order to determine catalyst

dendrimer-bound catalyst system in order to

functionality in differing solvent environments in

protonate the catalytic groups and run the

order to broaden possible reaction conditions.

reaction successfully. However, because of the
chance of the dendrimer framework being

During these solvent studies, multiple things

completely protonated and precipitating out of

were discovered about the practical process of the

solution, the reaction must be kept above a pH of

procedures in Scheme 2 and 3 with dendrimer-

3.

bound material. In the reaction shown in Scheme
3, an amber vial (preferably subsequently covered

Dialysis was used to purify the dendrimer

in tinfoil) must be used in order to prevent light

material from the reaction mixture, since the

degradation of the 1-phenylpyrrolidine starting

dendrimer material should stay in the dialysis

material. In the reaction shown in Scheme 3,

tubing as the reaction mixture diffuses outside of

there is also a cooling step to -10°C. When

the dialysis tubing. Dialysis in DMSO was

running the reaction in Scheme 3 with DMSO as

initially tried, but the lyophilization procedure

a solvent, the cooling step cannot be employed

from evaporating DMSO was time consuming.

7

Dialysis in DCM was also attempted, but it was

characterized by NMR, but MALDI-TOF-MS

found that DCM in large volumes degraded the

data shows a lower yield of cyclization (Table 1).

dialysis tubing and leeched cellulose into the
reaction mixture. Removing the cellulose from
the

reaction

mixture

added

an

extra

chromatography purification step (in addition to

Table 1: Percent functionalization for 8 and 4,5,6 by both NMR
and MALDI-TOF-MS

GENERATION

the chromatographic method to purify product
from reagents), so DCM was discarded as a
potential solvent for dialysis and the use of

PAMAM 8

PAMAM 4,5,6

MALDI

NMR

MALDI

NMR

G(2.0)

Quant.

Quant.

26%

86%

G(3.0)

91%

Quant.

32%

90%

G(4.0)

97%

Quant.

26%

93%

DMSO had evidence of being more efficient than
DCM in these conditions.

Because of the internal consistency of percent
functionalization found via both MALDI-TOF-

Purification of the desired products from the

MS and NMR spectroscopy, respectively, and

reactants

gel

due to the nature of the high-powered laser used

that

in MALDI-TOF-MS, it is theorized that the

chromatography using a Chromatotron (a

laser fragments the fragile fully cyclized catalyst

centrifugal thin-layer silica gel purification

functionalized dendrimer. Further investigation

system)23 with a hand-held UV lamp was more

is currently being conducted to determine

efficient, used less solvent, and provided better

another method of characterization to determine

separation and yields than classic flash or gravity

the

chromatography with silica gel.

dendrimers to confirm this theory.

RESULTS

Two reactions

was

chromatography.

performed
It

was

via

silica

found

free

mass

of

(2S,

the

catalyst

functionalized

published by MacMillan using
5S)-5-benzyl-2-tert-butyl-3-

Three generations of dendrimer-bound (2S, 5S)-

methylimidazolidin-4-one were investigated by

5-benzyl-2-tert-butyl-3-methylimidazolidin-4-

substituting free catalyst with dendrimer-bound

one were successfully synthesized with good

catalyst, and evidence shows that the dendrimer-

functionalization

bound catalyst both catalyzes these reactions and

functionalization

yield.
was

Phenylalanine

completed

in

near

quantitiative yield (Table 1, Steps 1 and 2 to

produces the same rotation in chirality in the
desired product. (Table 2).

produce 8 in Scheme 1). Cyclization into the
complete catalyst (Step 3 to produce 4,5,6 in
Scheme 1) was completed in high yield when

8

Table 2: Comparison of Free Catalyst and Dendrimer-Bound
Catalyst Activity
DENDRIMERFREE CATALYST
ANILINE

way to purify dendrimer-bound catalyst. (Table
3).

BOUND CATALYST

Yield

89%

32%

Optical

-2.77°

-0.4°

Table 3: Recovery of dendrimer-bound catalyst using dialysis

ADDITION
(DCM)

TRIAL NUMBER
Rotation

DIELS ALDER

Yield

24%

(ACN/WATER)

Optical

-536°

PERCENT
RECOVERY

(observed rotation)
4%

GENERATION

-460°

1

G (3.0)

14

2

G (3.0)

6

3

G (3.0)

43

4

G (2.0)

28

Rotation

There has not yet been any evidence of a
Since both control and on-dendrimer catalyzed

correlation between dendrimer generation used

reactions

and yield or recovery.

ran

to

completion

via

NMR

monitoring, the discrepancy in percent yield is
attributed to purification error. The optical

CONCLUSIONS

rotation for all products produced by dendrimerbound catalyst is concurrent with the chirality

Three generations (2.0, 3.0, and 4.0) of

observed with free catalyst, which is promising

dendrimer-bound

for future work because the optical rotation

butyl-3-methylimidazolidin-4-one catalyst have

provides evidence the dendrimer-bound catalyst

been successfully synthesized. The dendrimer-

works with similar enantioselectivity to the free

bound catalysts demonstrate similar yield and

catalyst.

optical activity to free (2S, 5S)-5-benzyl-2-tert-

(2S,

5S)-5-benzyl-2-tert-

butyl-3-methylimidazolidin-4-one catalyst as
Attempts to recover the dendrimer-bound

reported by MacMillan. The dendrimer-bound

catalyst were initially successful but are currently

catalysts also demonstrate higher potential for

being optimized. Purification of the dendrimer-

recovery of catalyst than free catalyst. Recovery

bound catalyst by filtration was initially seemed

methods are currently being optimized, most

promising because of limited dendrimer solubility

promisingly through dialysis techniques. The

in acetonitrile and water, but NMR analysis

efficiency of the dendrimer-bound catalyst after a

showed high levels of starting reagents trapped

number of uses and recoveries is also being

inside the dendrimer framework after washing of

investigated. Future work will include optimizing

the filtrate. Dialysis against DMSO using

catalytic conditions and developing orthogonal

regenerated cellulose dialysis tubing with a

catalysts for multistep or cascade catalysis, as well

MWCO of 3500 kDa proved a more efficient

as attempting different catalytic delivery and
recovery methods through the use of linking the
9

dendrimer-bound catalyst to a gold surface for
solid-support catalysis.
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EXPERIMENTALS
Generation 2.0 PAMAM-based nitrogen-

2.97, 3.01 (m, 16H, PhCH2CH), 3.21 (m, 96H,

linked phenylalanine dendrimer (8):

PAMAM-x), 3.50 (m, 16H, PhCH2CH), 7.20,

An aqueous solution of amine-terminated

7.28 (m, 80H, Ph) ppm; 13C NMR (500MHz,

Starburst PAMAM dendrimer (Generation 2.0,

CD3OD) δ 34.7, 38.6, 39.9, 40.4, 42.5, 51.1,

12.57% (w/w)) was lyophilized. The resulting

53.4, 57.9, 127.9, 129.7, 130.5, 139.0, 175.1,

residue (124.8 mg, 0.0383 mmol, 1 eq) was

176.9 ppm; MALDI-TOF-MS (pos) 5628.

dissolved in DMSO ( 1.0 mL). In a separate
scintillation

vial,

a

solution

of

9-

linked

fluorenylmethoxycarbonyl-L-phenylalanine
(0.9442

g,

2.43

mmol,

64

eq)

Generation 2.0 PAMAM-based nitrogen-

and

(2S,5S)-(-)-2-tert-butyl-3-methyl-5-

benzyl-4-imidazolidinone dendrimer (4):

hydroxybenzotriazole (0.3375 g, 2.49 mmol, 64
eq) in DMSO (4.0 mL) was added to a solution
of N,N'-diisopropylcarboimide (382 uL, 2.43
mmol, 64 eq) in DMSO (0.25 mL) and allowed
to stir for five minutes. The two solutions were
combined and stirred (2.5 h) to form 7. This
product was dialysed against DMSO (MW cutoff
1 kDa). The solution was lyophilized to give 7.
This

product

was

used

without

further

purification.

Phenylalanine functionalized G (2.0) PAMAM
(8) (126.6 mg, 0.2256 mmol, 1 eq) was dissolved
in dimethylformamide (1.5 mL) and pivaldehyde
was added (490 uL, 4.51 mmol, 200 eq). N, N'diisopropylethylamine was added until the
reaction mixture reached a pH of 9. The reaction
mixture was stirred for approximately 40 hours.
This product was lyophilized to remove DMF,
re-dissolved in DMSO and dialysed against
DMSO (MW cutoff 1 kDa). The solution was

Resulting crude product 7 was deprotected in a
20% (v/v) solution of piperidine/ DMSO by
dissolving in DMSO (7.0 mL) and adding
piperidine (1.75 mL). After 110 minutes of
stirring, the reaction mixture was dialysed against
DMSO (MW cutoff 1 kDa). The solution was
lyophilized using water to drive out DMSO to
give title compound (8) as a fluffy, white solid
(136.6 mg). 1H NMR (500MHz, CD3OD) δ
(ppm) 2.31 (m, 61H, PAMAM-x), 2.54 (m,
28H, PAMAM-x), 2.76 (m, 61H, PAMAM-x),

lyophilized using water to drive out DMSO to
give title compound 4 as a pale yellow glassy solid
(89.2 mg). [α]D= -131.5;

1

H NMR (500MHz,

CD3OD) δ 0.85 (s, 123H, tert-butyl) 2.31 (m,
60H, PAMAM-x) 2.52 (m, 28H, PAMAM-x),
2.74 (m, 61H, PAMAM-x) 3.21 (m, 96H,
PAMAM-x) 3.65, 3.69 (dd, 16H, PhCH2CH)
6.88, 7.06, 7.21 (m, 80H, Ph) ppm; 13C NMR
(500MHz, CD3OD) δ (ppm) 27.2, 34.8, 37.3,
38.7, 40.1, 40.5, 41.8, 42.6, 51.2, 53.6, 58.0, 76.1,
127.7, 129.4, 129.7, 130.6, 131.2, 138.9, 174.6,

11

174.7, 175.1, 175.5, 176.5, 177.0 ppm; MALDI-

(ppm) 2.33 (m, 124H, PAMAM-x), 2.56 (m,

TOF-MS (pos) 6118.

57H, PAMAM-x), 2.77 (m, 119H, PAMAMx), 2.96 (m, 61H, PhCH2CH), 3.21 (m, 182H,
PAMAM-x), 3.51 (m, 32H, PhCH2CH), 7.21,

Generation 3.0 PAMAM-based nitrogenlinked phenylalanine dendrimer (8):

7.28 (m, 169H, Ph);

13

C NMR (500MHz,

CD3OD) δ (ppm) 34.8, 28.6, 40.0, 40.4, 42.5,

An aqueous solution of amine-terminated
Starburst PAMAM dendrimer (Generation 3.0,

128.0, 129.6, 130.6, 139.1, 174.6, 175.1, 176.9
ppm; MALDI-TOF-MS (pos) 10606.

7.01% (w/w)) was lyophilized. The resulting
residue (116.8 mg, 0.0169 mmol, 1 eq) was
dissolved in DMSO ( 2.0 mL). In a separate
scintillation

vial,

a

solution

of

9-

fluorenylmethoxycarbonyl-L-phenylalanine
(0.8398

g,

2.17

mmol,

128

eq)

eq) in DMSO (3.0 mL) was added to a solution
of N,N'-diisopropylcarboimide (340 uL, 2.18
mmol, 128 eq) in DMSO (1.0 mL) and allowed
to stir for five minutes. The two solutions were
combined and stirred (2.5 h) to form 7. This
product was dialysed against DMSO (MW cutoff
3.5 kDa). The solution was lyophilized to give 7.
product

was

used

without

linked

(2S,5S)-(-)-2-tert-butyl-3-methyl-5-

benzyl-4-imidazolidinone dendrimer (5):
Phenylalanine functionalized G (3.0) PAMAM 8

and

hydroxybenzotriazole (0.2950 g, 2.18 mmol, 128

This

Generation 3.0 PAMAM-based nitrogen-

further

purification.

(122.2 mg, 0.012 mmol, 1 eq) was dissolved in
dimethylformamide (2.0 mL) and pivaldehyde
was added (228 uL, 2.05 mmol, 200 eq). N, N'diisopropylethylamine was added until the pH of
the reaction mixture reached 9. The reaction
mixture was stirred for approximately 40 hours.
This product was lyophilized to remove DMF,
re-dissolved in DMSO and dialysed against
DMSO (MW cutoff 3.5 kDa). The solution was
lyophilized using water to drive out DMSO to
give title compound 5 as a pale yellow glassy solid
(126.1 mg). 1H NMR (500MHz, CD3OD) δ

Resulting crude product 7 was deprotected in a
20% (v/v) solution of piperidine/ DMSO by
dissolving in DMSO (5.5 mL) and adding
piperidine (1.4 mL). After 60 minutes of stirring,
the reaction mixture was dialysed against DMSO
(MW cutoff 3.5 kDa). The solution was
lyophilized using water to drive out DMSO to
give title compound 8 as a fluffy, white solid
(122.2 mg). 1H NMR (300MHz, CD3OD) δ

0.89 (s, 252H, tert-butyl), 2.35 (m, 120H,
PAMAM-x), 2.57 (m, 56H, PAMAM-x) 2.78
(m, 121H, PAMAM-x), 3.25 (m, 185H,
PAMAM-x), 3.71, 3.74 (dd, 31H, PhCH2CH),
6.93, 7.09, 7.24 (m, 163H, Ph) ppm; 13C NMR

(500MHz, CD3OD) δ ppm 25.1, 25.8, 33.4,
35.9, 37.3, 38.7, 39.1, 40.4, 41.2, 49.8, 52.2,
56.6, 74.6, 126.3, 128.0, 128.3, 129.2, 129.8,
137.5, 173.7, 174.1, 175.1; (500MHz,
12

CD3OD) δ ppm; MALDI-TOF-MS (pos)

112H, PAMAM-x), 2.73 (m, 243H, PAMAM-

11372.

x), 2.98 (m, 63H, PhCH2CH), 3.21 (m, 368H,
PAMAM-x), 3.51 (64H, m, PhCH2CH),
13

Generation 4.0 PAMAM-based nitrogen-

7.19,7.25 (m, 319H, Ph) ppm;

linked phenylalanine dendrimer (8):

(500MHz, CD3OD) δ (ppm) 34.8, 38.7, 40.0,

An aqueous solution of amine-terminated

40.5, 42.6, 51.3, 53.6, 57.8, 127.9, 129.6, 130.6,

Starburst PAMAM dendrimer (Generation 4.0,

139.0, 175.2, 176.8 ppm; MALDI-TOF-MS

13.12% (w/w)) was lyophilized. The resulting

(pos) 21164.

C NMR

residue (123.7 mg, 0.0087 mmol, 1 eq) was
dissolved in DMSO ( 2.0 mL). In a separate

Generation 4.0 PAMAM-based nitrogen-

scintillation

linked

vial,

a

solution

of

9-

(2S,5S)-(-)-2-tert-butyl-3-methyl-5-

benzyl-4-imidazolidinone dendrimer (6):

fluorenylmethoxycarbonyl-L-phenylalanine
and

Phenylalanine functionalized G (4.0) PAMAM 8

hydroxybenzotriazole (0.3067 g, 2.27 mmol, 256

(151.8 mg, 0.0066 mmol, 1 eq) was dissolved in

eq) in DMSO (4.0 mL) was added to a solution

dimethylformamide (1.5 mL) and pivaldehyde

of N,N'-diisopropylcarboimide (346 uL, 2.22

was added (143 uL, 1.32 mmol, 200 eq). N, N'-

mmol, 256 eq) in DMSO (0.5 mL) and allowed

diisopropylethylamine was added until the pH of

to stir for five minutes. The two solutions were

the reaction mixture reached 9. The reaction

combined and stirred (2.5 h) to form 7. This

mixture was stirred for approximately 40 hours.

product was dialysed against DMSO (MW cutoff

This product was lyophilized to remove DMF,

3.5 kDa). The solution was lyophilized to give 7.

re-dissolved in DMSO and dialysed against

This

DMSO (MW cutoff 3.5 kDa). The solution was

(0.8622

g,

product

2.23

was

mmol,

used

256

eq)

without

further

purification.

lyophilized using water to drive out DMSO to
give title compound 6 as a pale yellow glassy solid

Resulting crude product 7 was deprotected in a

(99.3 mg). [α]D= -47.4; 1H NMR (500MHz,

20% (v/v) solution of piperidine/ DMSO by

CD3OD) δ 0.89 (s, 521H, tert-butyl), 2.35 (m,

dissolving in DMSO (7.0 mL) and adding

239H, PAMAM-x), 2.56 (m, 119H, PAMAM-

piperidine (1.75 mL). After 90 minutes of

x), 2.78 (m, 239H, PAMAM-x), 3.25 (m, 366H,

stirring, the reaction mixture was dialysed against

PAMAM-x), 3.71 (dd, 62, PhCH2CH), 6.92,

DMSO (MW cutoff 3.5 kDa). The solution was

7.08, 7.22 (m, 320H, Ph) ppm;

lyophilized using water to drive out DMSO to

(500MHz, CD3OD) δ 25.4, 26.4, 27.4, 35.0,

give title compound 8 as a fluffy, white solid

37.4, 40.2, 40.3, 40.7, 42.0, 51.3, 53.8, 58.1, 76.2,

(161.4 mg). 1H NMR (500MHz, CD3OD) δ

127.9, 129.6, 129.9, 131.4, 139.0, 139.3, 174.7,

13

C NMR

(ppm) 2.29 (m, 240H, PAMAM-x), 2.52 (m,

13

174.8, 175.2, 176.6, 177.0 ppm; MALDI-TOF-

salt/ice

bath

before

addition

of

1-

MS (pos) 22700.

phenylpyrrolidine (34.3 uL, 0.234 mmol, 3.0
equiv). After 16 d, the reaction mixture was

Acid-Catalyzed in Dichloromethane 3-(4-

transferred into dialysis tubing (MWCO 3500)

Nitrophenyl)-3-(4-pyrolidin-1-yl-phenyl)-

and dialyzed against DCM. The DCM outside

propionaldehyde

the dialysis tubing was concentrated in vacuo and

To a 5 mL amber scintillation vial equipped with

subjected to silica gel chromatography via

a

4-

chromatotron. Gradient elution with 25-50%

nitrocinnamaldehyde (13.7 mg, 0.077 mmol, 1.0

EtOAc in hexanes followed by concentration in

equiv) dichloromethane (0.2 mL), and HCl (as a

vacuo afforded the product as a bright orange oil

4N solution in 1,4-dioxane, 5 uL). The solution

in 32.4% yield (8.6 mg, 0.027 mmol); [α]obs= -0.4

magnetic

stir

bar

was

added

was cooled to -10°C in a salt/ice bath before
addition of 1-phenylpyrrolidine (35.1 uL, 0.244

Dendrimer-Bound

mmol, 3.0 equiv). After 48 h, the crude reaction

Dimethylsulfoxide (S)-3-(4-Nitrophenyl)-3-(4-

mixture was analyzed by NMR and product was

pyrolidin-1-yl-phenyl)-propionaldehyde

found

to

be

formed

in

a

Catalyst

in

4-

nitrocinnamaldehyde:product ratio of 1:1.2,

To a 5 mL amber scintillation vial equipped with

providing evidence that any additional product

a magnetic stir bar was added G(3.0) dendrimer-

formed after the 16 d mark in the on-dendrimer

bound

catalyst is due to catalytic activity, and not acid

methylimidazolidin-4-one (14.0 mg, 1.0 E-3

catalysis.

mmol, 0.20 equiv catalyst), dimethylsulfoxide

(2S,

5S)-5-benzyl-2-tert-butyl-3-

(0.45 mL), HCl to acidify the solution to pH ~4
Dendrimer-Bound

in

(as a 4N solution in 1,4-dioxane, 30 uL), and 4-

Dichloromethane (S)-3-(4-Nitrophenyl)-3-(4-

nitrocinnamaldehyde (24.1 mg, 0.136 mmol, 1.0

pyrolidin-1-yl-phenyl)-propionaldehyde

equiv). 1-phenylpyrrolidine was then added to

To a 5 mL amber scintillation vial equipped with

the vial (57.3 uL, 0.398 mmol, 2.98 equiv). After

a magnetic stir bar was added G(2.0) dendrimer-

20 d, the reaction mixture was transferred into

bound

dialysis tubing (MWCO 3500) and dialyzed

(2S,

Catalyst

5S)-5-benzyl-2-tert-butyl-39.7E-4

against DMSO. The DMSO outside the dialysis

mmol, 0.20 equiv catalyst), dichloromethane (0.5

tubing was concentrated under reduced pressure

mL), HCl to acidify the solution to pH ~4 (as a

in a lyophilizer and subjected to silica gel

4N solution in 1,4-dioxane, 20 uL), and 4-

chromatography via chromatotron. Gradient

nitrocinnamaldehyde (14.5 mg, 0.082 mmol, 1.0

elution with 25-50% EtOAc in hexanes followed

equiv). The solution was cooled to -10°C in a

by concentration in vacuo afforded the product as

methylimidazolidin-4-one

(6.5

mg,

14

a bright orange oil in 26.97% yield (11.9 mg,

(10 mL) and washed with water (10 mL). The

0.037 mmol); apparent [α]D= -1.89 (c=0.030

aqueous layer was extracted with diethyl ether (5

mmol, 1 mL CHCl3), 45% ee.

mL x 4) and the combined organics were dried
(Na2SO4) and concentrated. Purification by silica

Free Catalyst in Acetonitrile and Water (2R)-

gel chromatography (10% ether/pentane afforded

Bicyclo[2.2.2]oct-5-ene-2-carboxyaldehyde

the title compound as a colorless oil in 24% yield

To a 5 mL amber scintillation vial equipped with

(17.4

a magnetic stir bar was added (2S, 5S)-5-benzyl-

[α]D = -460° (c=3.7*10E-2 mmol, 1 mL CHCl3)

mg,

1.3*10E-4

mmol);

apparent

2-tert-butyl-3-methylimidazolidin-4-one (24.2
mg, 0.098 mmol), acetonitrile/water (95/5 v/v,

Free Catalyst in Dichloromethane (S)-3-(4-

0.13 mL), acrolein (500 uL, 7.48 mmol), and

Nitrophenyl)-3-(4-pyrolidin-1-yl-phenyl)-

cyclohexadiene (240 uL, 2.52 mmol). The

propionaldehyde

solution was stirred for 24 h, after which time the

To a 5 mL amber scintillation vial equipped with

reaction mixture was diluted with diethyl ether

a magnetic stir bar was added (2S, 5S)-5-benzyl-

(10 mL) and washed with water (10 mL). The

2-tert-butyl-3-methylimidazolidin-4-one (24.1

aqueous layer was extracted with diethyl ether (5

mg, 0.099 mmol, 0.20 equiv) dichloromethane

mL x 4) and the combined organics were dried

(1.0 mL), HCl (as a 4N solution in 1,4-dioxane,

(Na2SO4) and concentrated. Purification by silica

25 uL), and 4-nitrocinnamaldehyde (88.5 mg,

gel

ether/pentane)

0.500 mmol, 1.0 equiv). The solution was cooled

afforded the title compound as a colorless oil in

to -10°C in a salt/ice bath before addition of 1-

4% yield (14.0 mg, 0.10 mmol); apparent

phenylpyrrolidine (216 uL, 1.485 mmol, 3.0

[α]D= -535° (c=5.1*10E-6 mmol, 1 mL CHCl3)

equiv). After 48 h, the reaction mixture was

chromatography

(10%

subjected directly to silica gel chromatography.
Dendrimer-Bound
Dichloromethane

Catalyst

in

Gradient elution with 25-50% EtOAc in hexanes

(2R)-Bicyclo[2.2.2.]oct-5-

followed by concentration in vacuo afforded the

ene-2 carboxylaldehyde

product as a bright orange oil in 89% yield (162.1

To a 5 mL amber scintillation vial equipped with

mg, 0.500 mmol); apparent [α]D=-2.77 (c=0.37

a magnetic stir bar was added G(4.0) (2S, 5S)-5-

mmol, 1 mL CHCl3), 67%ee.

benzyl-2-tert-butyl-3-methylimidazolidin-4-one
(3.0 mg, 1.07*E-4 mmol), dichloromethane,

Free Catalyst in Dimethylsulfoxide (S)-3-(4-

acrolein

Nitrophenyl)-3-(4-pyrolidin-1-yl-phenyl)-

(6.5

uL,

0.097

mmol),

and

cyclohexadiene (5.0 uL, 0.052 mmol). The

propionaldehyde

solution was stirred for 8 d, after which time the

To a 5 mL amber scintillation vial equipped with

reaction mixture was diluted with diethyl ether

a magnetic stir bar was added (2S, 5S)-5-benzyl-

15

2-tert-butyl-3-methylimidazolidin-4-one (27.6

Characterization Notes

mg, 0.112mmol, 0.20 equiv) dimethylsulfoxide

1

(0.5 mL), HCl (as a 4N solution in 1,4-dioxane,

dendrimer characterization was carried out in

25 uL), and 4-nitrocinnamaldehyde (99.3mg,

deuterated methanol. 13C NMR was optimized

0.500 mmol, 1.0 equiv). The solution was cooled

by running 8,000-9,000 scans on samples with a

to -10°C in a salt/ice bath before addition of 1-

3 second relaxation delay.

H NMR and

13

C NMR for all functionalized

phenylpyrrolidine (241.8 uL, 1.68 mmol, 3.0
equiv). After 48 h, the reaction mixture was

Optimum MALDI-TOF-MS characterization

subjected directly to silica gel chromatography.

can be carried out in both trans-3-indolacrylic

Gradient elution with 25-50% EtOAc in hexanes

acid (IAA) or 2,5-dihydroxybenzoic acid (DHB)

followed by concentration in vacuo afforded the

with dimethylformamide (DMF) as a solvent

product as a bright orange oil in 69.5% yield

with the concentrations used in Table 4. It was

(126.4 mg, 0.390 mmol); apparent [α]D= -3.9

found that DHB provided more consistent

(c=0.34 mmol, 1 mL CHCl3), 94%ee

success in MALDI-TOF-MS analysis attempts.
Myoglobin was used as a standard for calibration

Free Catalyst in Dichloroethane (S)-3-(4-

purposes.

Nitrophenyl)-3-(4-pyrolidin-1-yl-phenyl)propionaldehyde

Myoglobin standards were prepared by adding 10

To a 5 mL amber scintillation vial equipped with

uL of myoglobin solution (1.6mg/mL H2O) to

a magnetic stir bar was added (2S, 5S)-5-benzyl-

10 uL of DHB solution (20 mg/mL DHB in 80%

2-tert-butyl-3-methylimidazolidin-4-one

ACN/H2O).

(25.6mg, 0.104mmol, 0.20 equiv) dichloroethane
(1.0yk mL), HCl (as a 4N solution in 1,4-

Table 4: Optimal Concentration Range for MALDI-

dioxane, 30 uL), and 4-nitrocinnamaldehyde

TOF-MS Analysis

(92.2 mg, 0.512 mmol, 1.02 equiv). The solution

Desired

uL

was cooled to -10°C in a salt/ice bath before

Concentration

Dendrimer

Matrix

Matrix

(Dendrimer:Matrix)

Solution

Solution

Solution

1:250

4

-

10

1:500

2

-

10

1:1000

1

-

10

1:2500

4

10

-

addition of 1-phenylpyrrolidine (223.0 uL, 1.55
mmol, 3.0 equiv). After 48 h, the reaction
mixture was subjected directly to silica gel
chromatography. Gradient elution with 25-50%
EtOAc in hexanes followed by concentration in

1mM

uL

1M

uL

1:5000

2

10

-

vacuo afforded the product as a bright orange oil

1:10k

1

10

-

in 47.6% yield (80.3 mg, 0.248 mmol); [α]D=-

1:20k

1

20

-

2.36 (c=0.13 mmol, 1 mL CHCl3), 57%ee

1:30k

1

30

-

16

0.1M

1M DHB Matrix solution was prepared by
adding 0.0231g of DHB to 150 uL of DMF.
0.1M DHB Matrix solution was prepared by
adding 20 uL of 1M DHB solution to 180 uL of
DMF.
1 mM dendrimer solutions were prepared
according to their theoretical mass based on
functionalization and generation (Table 5).
Table 5: Preparation of 1 mM dendrimer solutions.
Generation

Concentration Dendrimer

Concentration

8 in DMF

Dendrimers 4,5,6 in DMF

G (2.0)

5.5mg/mL

6.7 mg/mL

G (3.0)

12 mg/mL

14 mg/mL

G (4.0)

24 mg/mL

28 mg/mL
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